Brief: Nexalin Technology Announces Positive Results From Clinical Study Of Gen-2 tACS Device For Treating Adult Patients With Chronic Insomnia

Nexalin Technology

06/03/2024 13:50

March 6 (Reuters) - Nexalin Technology Inc  NXL.O :
    * NEXALIN TECHNOLOGY ANNOUNCES POSITIVE RESULTS FROM
CLINICAL
STUDY OF ITS GEN-2 TACS DEVICE FOR TREATING ADULT PATIENTS WITH
CHRONIC INSOMNIA
    * NEXALIN TECHNOLOGY INC: STUDY SHOWED STATISTICALLY
SIGNIFICANT
IMPROVEMENTS IN KEY SLEEP PARAMETERS, COMPARED TO ADULT PATIENTS
TREATED WITH PLACEBO
    * NEXALIN TECHNOLOGY INC: OLDER PARTICIPANTS (AGES 50 AND
OVER)
EXPERIENCED COMPARATIVELY MORE SIGNIFICANT BENEFITS FROM TACS

Source text for Eikon:  ID:nGNX6pHxlB 
Further company coverage:  NXL.O 

 ((Reuters.Briefs@thomsonreuters.com;))